JP2004515202A5 - - Google Patents

Download PDF

Info

Publication number
JP2004515202A5
JP2004515202A5 JP2000571873A JP2000571873A JP2004515202A5 JP 2004515202 A5 JP2004515202 A5 JP 2004515202A5 JP 2000571873 A JP2000571873 A JP 2000571873A JP 2000571873 A JP2000571873 A JP 2000571873A JP 2004515202 A5 JP2004515202 A5 JP 2004515202A5
Authority
JP
Japan
Prior art keywords
antibody
malignin
peptide
concentration
tag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000571873A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004515202A (ja
Filing date
Publication date
Priority claimed from US09/146,755 external-priority patent/US6242578B1/en
Application filed filed Critical
Publication of JP2004515202A publication Critical patent/JP2004515202A/ja
Publication of JP2004515202A5 publication Critical patent/JP2004515202A5/ja
Withdrawn legal-status Critical Current

Links

Images

JP2000571873A 1998-09-04 1999-08-30 アグリコ生成物及び利用法 Withdrawn JP2004515202A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/146,755 US6242578B1 (en) 1994-02-17 1998-09-04 Aglyco products and methods of use
PCT/US1999/019836 WO2000018351A2 (en) 1998-09-04 1999-08-30 Aglyco products and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010263994A Division JP2011087589A (ja) 1998-09-04 2010-11-26 アグリコ生成物及び利用法

Publications (2)

Publication Number Publication Date
JP2004515202A JP2004515202A (ja) 2004-05-27
JP2004515202A5 true JP2004515202A5 (https=) 2010-04-22

Family

ID=22518867

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000571873A Withdrawn JP2004515202A (ja) 1998-09-04 1999-08-30 アグリコ生成物及び利用法
JP2010263994A Pending JP2011087589A (ja) 1998-09-04 2010-11-26 アグリコ生成物及び利用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010263994A Pending JP2011087589A (ja) 1998-09-04 2010-11-26 アグリコ生成物及び利用法

Country Status (13)

Country Link
US (4) US6242578B1 (https=)
EP (2) EP1115418B1 (https=)
JP (2) JP2004515202A (https=)
KR (1) KR100451446B1 (https=)
CN (2) CN1328286C (https=)
AT (1) ATE406175T1 (https=)
AU (1) AU771836B2 (https=)
BR (1) BR9913446A (https=)
CA (1) CA2341763C (https=)
DE (1) DE69939430D1 (https=)
IL (3) IL141775A0 (https=)
NZ (4) NZ510921A (https=)
WO (1) WO2000018351A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176275B2 (en) * 1998-09-04 2007-02-13 Samuel Bogoch Anthrax and small pox replikins and methods of use
DE10034712A1 (de) * 2000-07-17 2002-02-07 Arimedes Biotechnology Gmbh Verbrückte Glykokonjugate
US7894999B2 (en) 2001-03-27 2011-02-22 Samuel Bogoch Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
US7774144B2 (en) * 2001-10-26 2010-08-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
US7452963B2 (en) * 2001-03-27 2008-11-18 Samuel Bogoch Replikin peptides and antibodies therefore
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
NZ592340A (en) * 2001-03-27 2012-12-21 Elenore S Bogoch A method for making a virus vaccine compising Replikin peptides
CA2441540A1 (en) 2001-03-27 2002-10-31 Samuel Bogoch Replikin peptides and uses thereof
US7442761B2 (en) 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US7189800B2 (en) 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
SG173212A1 (en) * 2001-07-09 2011-08-29 Samuel Bogoch Replikin peptides and uses thereof
WO2003005880A2 (en) 2001-07-09 2003-01-23 Samuel Bogoch Replikin peptides and uses thereof
US7306919B1 (en) 2001-10-31 2007-12-11 Thornthwaite Jerry T Antigen-antibody cancer recognition system
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9254315B2 (en) 2004-04-28 2016-02-09 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9002652B1 (en) * 2005-01-27 2015-04-07 Institute For Systems Biology Methods for identifying and using organ-specific proteins in blood
WO2006088962A2 (en) 2005-02-16 2006-08-24 Samuel Bogoch Replikin peptides and uses thereof
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
JP2006288670A (ja) * 2005-04-11 2006-10-26 Terumo Corp カテーテル
EP2092059A4 (en) * 2006-10-24 2012-03-28 Bogoch Samuel METHOD FOR FORECASTING INFLUENZA EXCESSIONS BY CORRELATION OF AN INCREASED REPLICINE MIRROR IN WHITE SPOT AND / OR TAURA VIRUSES IN CRABES
EP2126140A4 (en) 2007-01-18 2012-03-28 Samuel Bogoch METHOD FOR DETERMINING THE MORTALITY OF PATHOGENS AND MALIGNOMAS WITH REPLICINE TIPS
US20100105634A1 (en) * 2007-03-07 2010-04-29 Cargill, Incorporated Use of glucosamine as a mental and physical stress recovery enhancer and a performance enhancer
CA2689181A1 (en) * 2007-05-30 2008-12-24 Samuel Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
US20090269367A1 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
US20100144589A1 (en) * 2008-08-08 2010-06-10 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298590A (en) * 1975-02-25 1981-11-03 Samuel Bogoch Detection of malignant tumor cells
US4840915A (en) * 1975-02-25 1989-06-20 Brain Research, Inc. Method for diagnosing malignant tumors
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
US5280113A (en) 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
GB9202219D0 (en) 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
EP0812191B1 (en) * 1995-04-11 2005-07-20 Samuel Dr. Bogoch Peptides for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2004515202A5 (https=)
CA1250100A (en) Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
CA2341763C (en) Antigenic peptides of aglyco 10b and antibodies thereto
JP2008074867A (ja) ペプチドリガンドを介して結合された複数の免疫原性成分を有するｈｂｖコア抗原粒子
JP2003502283A5 (https=)
JPS63183600A (ja) ヒト乳頭腫ウイルスの診断用ペプチド
WO2021233885A1 (en) Mimotope peptides of the spike protein from the sars-cov-2 virus
US5616685A (en) snRNP-A antigen and fragments thereof
JP2598245B2 (ja) Ｈｔｌｖ−ｉｉｉ／ｌａｖウイルス関連ペプチドに対する抗体
KR20090041416A (ko) 비만증을 억제하는 백신 및 방법
JP3767755B2 (ja) 抗ｊｃウイルス抗体
JP2886979B2 (ja) タンパク質複合体
JPS61143328A (ja) リンパ節疾患及び後天性免疫不全症候群の病因物質からｔリンパ球を保護するための組成物及び方法
JP2003502285A (ja) Ｔｔウイルス配列由来のペプチドおよびｔｔウイルスに結合する単一特異性抗体
CN112262153B (zh) 高效的肝炎病毒的抗体诱导方法、抗体以及检测系统
Stein et al. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe extracts
ES2207753T3 (es) Nuevos inhibidores de la hepatitis b.
CN116059348A (zh) 基于nkg2d的细胞接合器分子在清除衰老细胞中的应用
WO1986005400A1 (en) Antigens, antibodies and their uses
JP5836968B2 (ja) ＩｇＥ媒介性疾患の処置方法
US20040137016A1 (en) Pre-S protein of hepatitis B virus (HBV) as an adjuvant and a component of HBV vaccine
FR2794864A1 (fr) Methode de detection precoce des flavivirus et ses applications
JPH10508591A (ja) 同種タンパク質および異種タンパク質に対する抗体、診断および治療におけるそれらの用途ならびにそれらを測定する方法
US20240132576A1 (en) Coronavirus: early detection and treatment
JP4667578B2 (ja) Ｃ型肝炎ウイルスの新規なｃｔｌエピトープ